Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000503651 | SCV000596716 | uncertain significance | not specified | 2016-10-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002316445 | SCV000850672 | benign | Inborn genetic diseases | 2019-02-09 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV000765339 | SCV000896602 | uncertain significance | Smith-Magenis syndrome | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001584218 | SCV001819789 | likely benign | not provided | 2021-03-01 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24205348, 21857958) |
Labcorp Genetics |
RCV001584218 | SCV002404655 | benign | not provided | 2023-12-23 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003902790 | SCV004718326 | likely benign | RAI1-related disorder | 2023-09-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |